Pharmaceutical / Drug Definition :
Promotes vascular constriction and relieves migraine by stimulating specific 5-HT receptors in intracranial blood vessels and sensory trigeminal nerves
FDA Label Requirements and Exceptions
Almotriptan Malate
FDA Import Information
Almotriptan Malate
FDA Detentions
Almotriptan Malate (Almotriptan Malate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Almotriptan Malate (Almotriptan Malate Suppliers)
- Processors Almotriptan Malate
- Repackers Almotriptan Malate
- Relabelers Almotriptan Malate
- Exporters Almotriptan Malate
- Importers Almotriptan Malate
For more information about Almotriptan Malate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
